Neuland Laboratories Ltd

NEULANDLAB

Company Profile

  • Business description

    Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.

  • Contact

    Road No. 82, Jubilee Hills
    Plot No. 573A-III, Phoenix IVY Building
    11th Floor (5th Office Level)
    HyderabadTG500033
    IND

    T: +91 4067611600

    https://www.neulandlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    3,304

Stocks News & Analysis

stocks

ASX property share lifts guidance despite sector headwinds

Aussie property manager lifts earnings expectations despite interest rate uncertainty.
stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,945.2066.700.75%
CAC 408,239.5866.470.81%
DAX 4025,283.0298.130.39%
Dow JONES (US)50,461.68118.02-0.23%
FTSE 10010,502.5811.190.11%
HKSE25,328.23271.22-1.06%
NASDAQ26,656.18312.211.19%
Nikkei 22564,999.413.320.01%
NZX 50 Index13,227.81158.071.21%
S&P 5007,519.1245.650.61%
S&P/ASX 2008,717.7065.500.76%
SSE Composite Index4,093.7351.65-1.25%

Market Movers